Rating #78
Larry Robbins
Glenview Capital Management
Portfolio value
Stocks
Performance
1 Year
+12.05%
Stock Holdings
$
%
1Y
3Y
5Y
10Y
Larry Robbins’ Portfolio: Q1 2026
Top10 stocks: 60.92% of the portfolio
Larry Robbins’ Trades: Q1 2026
Adds
New Buys
Sold Outs
Cuts
1.61ppt
1.78ppt
1.45ppt
1.09ppt
1.61ppt
0.50ppt
1.27ppt
1.42ppt
0.93ppt
1.01ppt
Company Name | Share Count Chg. (%) | Price Paid | Buy Value | Portfolio % Change | |
|---|---|---|---|---|---|
1  META | Add +959.99% | $640.86 | $71.19M | 1.61ppt | |
2  CI | Add +78.56% | $276.68 | $60.72M | 1.78ppt | |
3  UBER | Add +105.72% | $76.97 | $57.59M | 1.45ppt | |
4  CNC | Add +73.16% | $41.00 | $55.67M | 1.09ppt | |
5  AMD | Add +65.10% | $213.52 | $54.79M | 1.61ppt | |
6  GENI | Add +321.68% | $7.12 | $46.50M | 0.50ppt | |
7  AMZN | Add +16.50% | $220.17 | $33.03M | 1.27ppt | |
8  GPN | Add +7.42% | $73.75 | $32.40M | 1.42ppt | |
9  XYZ | Add +60.24% | $60.80 | $31.19M | 0.93ppt | |
10  AMAT | Add +52.10% | $336.38 | $22.72M | 1.01ppt |
Larry Robbins’ Holdings: Q1 2026
Company Name | Primary Industry | Avg. price paid  | Share Count Chg. (%) | No of shares held | Market value | Portfolio % Change | % of Ownership | Holding period | Last Transaction | |
|---|---|---|---|---|---|---|---|---|---|---|
1  CVS | Retail-Drug Stores | $62.26 | 0.00% | 8.20M | $588.69M | 14.78% 1.54ppt | 0.65% | 10 Quarters | Q2 2025 | |
2 GPN | Other Business Services | $108.18 | Add +7.42% | 6.36M | $428.05M | 10.75% 1.42ppt | 2.65% | 22 Quarters | Q1 2026 | |
3  THC | Other General Medical Hospitals | $63.97 | Cut -23.13% | 1.52M | $287.76M | 7.22% -0.80ppt | 1.68% | 54 Quarters | Q1 2026 | |
4 AMZN | Retail-Catalog & Mail-Order | $193.35 | Add +16.50% | 1.06M | $220.61M | 5.54% 1.27ppt | 0.01% | 22 Quarters | Q1 2026 | |
5  TEVA | Pharmaceutical Pres | $14.91 | Cut -60.17% | 6.66M | $200.61M | 5.04% -5.58ppt | 0.58% | 10 Quarters | Q1 2026 | |
- | $577.18 | New Buy +100.00% | 328.20K | $189.43M | 4.76% 4.76ppt | - | 1 Quarter | Q1 2026 | ||
7 CI | Medical Service Plans | $261.39 | Add +78.56% | 498.84K | $133.07M | 3.34% 1.78ppt | 0.19% | 30 Quarters | Q1 2026 | |
8 AMD | Semiconductors | $209.93 | Add +65.10% | 650.79K | $132.39M | 3.32% 1.61ppt | 0.04% | 2 Quarters | Q1 2026 | |
9  TMO | Other Measuring Devices | $460.57 | Add +11.87% | 250.53K | $123.14M | 3.09% 0.45ppt | 0.07% | 4 Quarters | Q1 2026 | |
10  VTRS | Pharmaceutical Pres | $11.51 | Cut -18.04% | 9.09M | $122.77M | 3.08% 0.27ppt | 0.79% | 10 Quarters | Q1 2026 | |
11  DXC | Data Processing Services | $26.91 | Add +6.97% | 8.90M | $111.82M | 2.81% 0.33ppt | 5.02% | 36 Quarters | Q1 2026 | |
12 CNC | Medical Service Plans | $36.96 | Add +73.16% | 3.21M | $105.21M | 2.64% 1.09ppt | 0.65% | 8 Quarters | Q1 2026 | |
13 UBER | Other Business Services | $72.70 | Add +105.72% | 1.46M | $104.72M | 2.63% 1.45ppt | 0.07% | 20 Quarters | Q1 2026 | |
14  GTM | Interactive Media and Services | $5.13 | Cut -20.49% | 15.91M | $95.11M | 2.39% -1.75ppt | 0.00% | 8 Quarters | Q1 2026 | |
15 I IWM Put | - | $248.00 | New Buy +100.00% | 375.00K | $93.00M | 2.33% 2.33ppt | - | 1 Quarter | Q1 2026 | |
16 XYZ | Prepackaged Software | $64.94 | Add +60.24% | 1.36M | $82.11M | 2.06% 0.93ppt | 0.22% | 3 Quarters | Q1 2026 | |
17 META | Computer Programming & Data | $581.85 | Add +959.99% | 122.66K | $70.18M | 1.76% 1.61ppt | 0.01% | 5 Quarters | Q1 2026 | |
18 AMAT | Semiconductors | $286.04 | Add +52.10% | 197.21K | $67.40M | 1.69% 1.01ppt | 0.02% | 2 Quarters | Q1 2026 | |
19  ONTO | Other Measuring Devices | $139.18 | Cut -27.75% | 299.72K | $61.46M | 1.54% 0.21ppt | 0.61% | 3 Quarters | Q1 2026 | |
20  DKS | Retail-Shopping Goods | $201.86 | Add +5.28% | 298.91K | $59.27M | 1.49% 0.34ppt | 0.36% | 4 Quarters | Q1 2026 |
NEWSLETTER
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersOur content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.